Clinical and Molecular Characterization ofPROM1-Related Retinal Degeneration

Importance

ThePROM1gene,commonly associated with cone-rod dystrophies, may have dominant or recessive phenotypes that influence disease onset and severity.

Objective

To characterize the clinical phenotype and molecular genetic variations in patients withPROM1variants.

Design, Setting, and Participants

This case-series study was conducted at 2 specialist retinal genetics clinics and examined 19 consecutively enrolled patients withPROM1-related retinal degeneration. Data were collected and analyzed from May 2018 to December 2018.

Main Outcomes and Measures

Results of ophthalmic examination, retinal imaging, and molecular genetic analysis by next-generation sequencing.

Results

Of 19 patients, 13 (68%) were women, and age ranged from 11 to 70 years. All patients presented with central visual loss, with or without photophobia. Individuals with recessive variants commonly had severe loss of visual acuity by their 20s, whereas the dominant variant was associated with a milder phenotype, with most patients retaining good vision into late adulthood. The recessive cases were associated with a panretinal dystrophy of cone-rod phenotype with early macular involvement, whereas the dominant variants were associated with a cone-rod phenotype that was restricted to the macula with predominantly cone dysfunction. Next-generation sequencing identified 3 novel and 9 previously reported variants inPROM1. Recessive mutations included 6 truncating variants (3 nonsense and 3 frameshift), 4 splice site variants, and 1 missense variant. All 6 dominant variants were associated with a c.1117C>T missense variant. The variants were distributed throughout thePROM1genomic sequence with no specific clustering on protein domains.

Conclusions and Relevance

In this case-series study,PROM1recessive variants were associated with early-onset, severe panretinal degeneration. The similar phenotypes observed in patients with homozygous missense variants and splice site variants compared with similarly aged patients with truncating variants suggests that all recessive variants have a null (or loss of function close to null) outcome onPROM1function. In contrast, the dominant missense cases were associated with a milder, cone-driven phenotype, suggesting that the dominant disease is preferentially associated with cones. This has implications for the development of treatments for this severely blinding disease, and adeno-associated viral vector–based gene therapy and optogenetics could become successful treatment options.